Macroview Investment Management LLC Neurocrine Biosciences Inc Transaction History
Macroview Investment Management LLC
- $96.8 Million
- Q3 2024
A detailed history of Macroview Investment Management LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Macroview Investment Management LLC holds 97 shares of NBIX stock, worth $13,135. This represents 0.01% of its overall portfolio holdings.
Number of Shares
97
Previous 23
321.74%
Holding current value
$13,135
Previous $3,000
266.67%
% of portfolio
0.01%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding NBIX
# of Institutions
626Shares Held
94MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$1.92 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.35 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$697 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$349 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$252 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...